Premium
Breast‐conserving therapy (BCT) for early‐stage breast cancer
Author(s) -
Benda Rashmi K.,
Mendenhall Nancy Price,
Lind D. Scott,
Cendan Juan C.,
Shea Barbara F.,
Richardson Lisa C.,
Copeland Edward M.
Publication year - 2004
Publication title -
journal of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.201
H-Index - 111
eISSN - 1096-9098
pISSN - 0022-4790
DOI - 10.1002/jso.20000
Subject(s) - medicine , breast cancer , stage (stratigraphy) , quality of life (healthcare) , oncology , intervention (counseling) , disease , cancer , nursing , paleontology , biology
Several patient and tumor factors go into the decision process to determine whether a breast cancer patient is a good candidate for breast‐conserving therapy. The patient must be seen by all disciplines before any therapeutic intervention. When used appropriately, breast‐conserving therapy produces maximal disease control and improves quality of life in patients with early‐stage breast cancer. J. Surg. Oncol. 2004;85:14–27. © 2003 Wiley‐Liss, Inc.